Agouron Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGOURON PHARMS, and what generic and branded alternatives to AGOURON PHARMS drugs are available?
AGOURON PHARMS has three approved drugs.
Drugs and US Patents for Agouron Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Agouron Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 020779-001 | Mar 14, 1997 | 6,162,812*PED | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | POWDER;ORAL | 020778-001 | Mar 14, 1997 | 5,484,926*PED | ⤷ Sign Up |
Agouron Pharms | VIRACEPT | nelfinavir mesylate | TABLET;ORAL | 021503-001 | Apr 30, 2003 | 5,484,926*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.